CLON: Drug Development
CLON presents new possibilities in drug development through innovative research.
About CLON
We conduct drug development projects such as metastasis inhibitors and Parkinson's disease treatments. Through collaboration with customers, we strive to solve global challenges. Additionally, we focus on the early stages of research and development for drug development, aiming for successful research outcomes.
Innovative Research
Drug development research utilizing the latest technologies
Collaboration-Focused
Close collaboration with domestic and international researchers
Challenging Approaches
Research that maximizes the use of data
Ongoing Projects
CLON focuses on the early stages of new drug development, from active compound screening to lead compound development. Through the latest technologies and expertise, we achieve innovative results and efficiently complete the early stages of projects in collaboration with customers.
Metastasis Inhibitor
Developing innovative therapeutics that effectively inhibit metastasis
- •Target protein analysis
- • Candidate optimization
- • Mechanism of action research
Radiation Sensitizer
Developing anticancer drugs that enhance the effects of radiation therapy
- •Radiation sensitivity analysis
- • Combination therapy research
- • Minimizing side effects
Parkinson's Disease Treatment
Developing innovative treatments in collaboration with Professor Wonki Cho from KAIST
- •Neurotransmitter regulation
- • Blood-brain barrier penetration
- • Ensuring long-term efficacy
Development Process
Mechanism Research
Analyzing disease mechanisms and selecting target proteins
- •Disease mechanism analysis
- • Target protein validation
- • Binding structure prediction
Active Compound Discovery
Effective candidate screening using FEP Similar
- •Virtual screening
- • Activity validation
- • Structural optimization
Lead Compound Optimization
Improving drug properties and optimizing efficacy
- •Improving drug properties
- • Enhancing efficacy
- • Reducing toxicity
Collaboration Methods
Joint Drug Development
Carrying out drug development projects in collaboration with domestic and international pharmaceutical companies
- •Collaboration-focused
- • Expertise integration
- • Securing market competitiveness
Technology Transfer
Out-licensing of developed drug candidates
- •Securing profitability
- • Accelerating market entry
- • Global expansion
Competitive Advantages in Development
CLON aims to simplify the complex early drug development process and achieve fast and efficient drug development.
Technical Excellence
- •Utilization of FEP Similar technology
- • AI-based drug design
- • Rapid development speed
Cost Efficiency
- •Reducing development costs
- • High success rates
- • Efficient resource utilization
Innovative Drug Development Together
Start next-generation drug development with CLON from Tinaclon. Our innovative technologies and expertise will lead your research to success.